Caracterização estrutural e biofísica de duas proteínas relacionadas: β-1,3-1,4-glicanase de Bacillus subtilis 168 e α-L-arabinofuranosidase termoestável de Thermotoga petrophila RKU-1

Pós-graduação em Biofísica Molecular - IBILCE

Da apropriação indébita previdenciária (Art. 168-A, parágrafo 1, Inciso I do Código Penal) e sua efetiva materialização no plano da tipicidade

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Dissecting structure-function-stability relationships of a thermostable GH5-CBM3 cellulase from Bacillus subtilis 168

Cellulases participate in a number of biological events, such as plant cell wall remodelling, nematode parasitism and microbial carbon uptake. Their ability to depolymerize crystalline cellulose is of great biotechnological interest for environmentally compatible production of fuels from lignocellulosic biomass. However, industrial use of cellulases is somewhat limited by both their low catalytic efficiency and stability. In the present study, we conducted a detailed functional and structural characterization of the thermostable BsCe15A (Bacillus subtilis cellulase 5A), which consists of a GH5 (glycoside hydrolase 5) catalytic domain fused to a CBM3 (family 3 carbohydrate-binding module). NMR structural analysis revealed that the Bacillus CBM3 represents a new subfamily, which lacks the classical calcium-binding motif, and variations in NMR frequencies in the presence of cellopentaose showed the importance of polar residues in the carbohydrate interaction. Together with the catalytic domain, the CBM3 forms a large planar surface for cellulose recognition, which conducts the substrate in a proper conformation to the active site and increases enzymatic efficiency. Notably, the manganese ion was demonstrated to have a hyper-stabilizing effect on BsCel5A, and by using deletion constructs and X-ray crystallography we determined that this effect maps to a negatively charged motif located at the opposite face of the catalytic site.

Apical surgery: endoscopic findings at the resection level of 168 consecutively treated roots

Endoscopic evaluation of the cut root face after root-end resection during apical surgery.

Geschichte der Juden vom Abschluß des Talmud (500) bis zum Aufblühen der jüdisch-spanischen Cultur (1027)

von H. Graetz

Geschichte der Juden vom Abschluß des Talmud (500) bis zum Aufblühen der jüdisch-spanischen Cultur (1027)

von H. Graetz

Geschichte der Juden vom Aufblühen der jüdisch-spanischen Cultur (1027) bis Maimuni's Tod (1205)

von H. Graetz

Geschichte der Juden vom Abschluß des Talmud (500) bis zum Aufblühen der jüdisch-spanischen Cultur (1027)

von H. Graetz

Geschichte der Juden vom Aufblühen der jüdisch-spanischen Cultur (1027) bis Maimuni's Tod

von H. Graetz

Geschichte der Juden vom Abschluß des Talmuds (500) bis zum Aufblühen der jüdisch-spanischen Kultur (1027)

von H. Graetz. Bearb. von S. Eppenstein

Ms. hebr. oct. 168 - Kerakh Frankfurt : Skizzen zur Geschichte der Juden in Frankfurt am Main

Vorbesitzer: Eljāqīm Carmoly

Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice

BackgroundHepatorenal tyrosinaemia (Tyr 1) is a rare inborn error of tyrosine metabolism. Without treatment, patients are at high risk of developing acute liver failure, renal dysfunction and in the long run hepatocellular carcinoma. The aim of our study was to collect cross-sectional data.MethodsVia questionnaires we collected retrospective data of 168 patients with Tyr 1 from 21 centres (Europe, Turkey and Israel) about diagnosis, treatment, monitoring and outcome. In a subsequent consensus workshop, we discussed data and clinical implications.ResultsEarly treatment by NTBC accompanied by diet is essential to prevent serious complications such as liver failure, hepatocellular carcinoma and renal disease. As patients may remain initially asymptomatic or develop uncharacteristic clinical symptoms in the first months of life newborn mass screening using succinylacetone (SA) as a screening parameter in dried blood is mandatory for early diagnosis. NTBC-treatment has to be combined with natural protein restriction supplemented with essential amino acids. NTBC dosage should be reduced to the minimal dose allowing metabolic control, once daily dosing may be an option in older children and adults in order to increase compliance. Metabolic control is judged by SA (below detection limit) in dried blood or urine, plasma tyrosine (<400 ¿M) and NTBC-levels in the therapeutic range (20¿40 ¿M). Side effects of NTBC are mild and often transient.Indications for liver transplantation are hepatocellular carcinoma or failure to respond to NTBC. Follow-up procedures should include liver and kidney function tests, tumor markers and imaging, ophthalmological examination, blood count, psychomotor and intelligence testing as well as therapeutic monitoring (SA, tyrosine, NTBC in blood).ConclusionBased on the data from 21 centres treating 168 patients we were able to characterize current practice and clinical experience in Tyr 1. This information could form the basis for clinical practice recommendations, however further prospective data are required to underpin some of the recommendations.